NCT05425485

Brief Summary

Based on recent guidelines, the investigators have developed a parallel (patient and physician) educational web-based tool. To prove its effectiveness, the investigators have designed a cluster clinical trial of a 6-month duration in which 15 centres will be randomised to receive access and instruction on the strategy or to continue standard care. The trial endpoint is adherence at the patient level, for which each centre will recruit 15 consecutive patients and measure adherence (medication, physical activity, Mediterranean diet) and disease activity as of baseline and 6 months after.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
142

participants targeted

Target at P50-P75 for not_applicable rheumatoid-arthritis

Timeline
Completed

Started Oct 2022

Shorter than P25 for not_applicable rheumatoid-arthritis

Geographic Reach
1 country

15 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 9, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 21, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

October 1, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2023

Completed
Last Updated

November 27, 2023

Status Verified

November 1, 2023

Enrollment Period

1.1 years

First QC Date

June 9, 2022

Last Update Submit

November 23, 2023

Conditions

Keywords

Therapeutic adherencePatient education

Outcome Measures

Primary Outcomes (1)

  • Number of patients with therapeutic adherence.

    Score ≥ 80% both in the Compliance Questionnaire in Rheumatology (CQR) plus the in Adherence Medication Scale (RAM).

    6 months

Secondary Outcomes (5)

  • Adherence to physical exercise

    6 months

  • Adherence to mediterranean diet

    6 months

  • Disease activity

    6 months

  • Degree of satisfaction with medical care

    6 months

  • Health-related quality of life measured using the Short-form12 (SF-12) version 2 questionnaire, a shortened version of the SF-36

    6 months

Study Arms (2)

EducAR strategy

ACTIVE COMPARATOR

Healthcare personnel involved in the care of patients with RA in the selected centres will be provided with access to a website and instructed in its use in a videoconference. The website includes a training section for healthcare professionals and another for patients. The former includes explanatory videos on how to manage doctor-patient communication and to facilitate adherence and what not to do, tools to explain treatment options (shared decision aids) and links to key documents. The patient section includes information for patients (downloadable in leaflet format), medication calendars and disease diaries, videos explaining medication administration in RA and links to patient associations, among other tools. Both access to the website and its materials and to the instruction session will be open to all those involved in the corresponding service, but will not be mandatory.

Behavioral: Multi-component intervention

Standard of care

NO INTERVENTION

Physicians in the control group will not be instructed and will have no access to the materials included in the physician section of the webpage.

Interventions

Web-based strategy with processes, materials, and patient and doctor education formats.

Also known as: EducAR
EducAR strategy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (\>18 years of age)
  • RA according to diagnosis recorded in clinical records
  • \< 2 years since diagnosis of rheumatoid arthritis.
  • Independent daily living.

You may not qualify if:

  • Cognitive impairment
  • Language barriers
  • Impossibility of follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (15)

Hospital Universitari Germans Trias i Pujol

Badalona, Spain

Location

Hospital Universitario Reina Sofía

Córdoba, Spain

Location

Hospital General Universitario de Elda

Elda, Spain

Location

Hospital Universitari d'Igualada

Igualada, Spain

Location

Hospital Universitario de Bellvitge

L'Hospitalet de Llobregat, Spain

Location

Hospital de la Princesa

Madrid, 28006, Spain

Location

Hospital Universitario Ramón y Cajal

Madrid, Spain

Location

Hospital General Universitario de Málaga

Málaga, Spain

Location

Hospital Clínico Universitario Virgen de la Arrixaca

Murcia, Spain

Location

Hospital Universitario de Navarra

Pamplona, Spain

Location

Hospital Universitario de Canarias

San Cristóbal de La Laguna, Spain

Location

Hospital Universitario Nuestra Señora de la Candelaria

Santa Cruz de Tenerife, Spain

Location

Hospital Universitario Virgen Macarena

Seville, Spain

Location

Hospital Mutua de Terrassa

Terrassa, Spain

Location

Hospital Clínico Universitario de Valencia

Valencia, Spain

Location

Related Publications (1)

  • Ahijon Lana M, Sivera Mascaro F, Fernandez-Nebro A, Muntadas Castello S, Perez M, Oton T, Garcia de Yebenes MJ, Carmona L; EDUCAR Group. EducAR: implementing a multicomponent strategy to improve therapeutic adherence in rheumatoid arthritis. RMD Open. 2025 Feb 27;11(1):e004989. doi: 10.1136/rmdopen-2024-004989.

MeSH Terms

Conditions

Arthritis, RheumatoidTreatment Adherence and Compliance

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesHealth BehaviorBehavior

Study Officials

  • María Ahijon

    Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The patients are invited to participate in an observational study of adherence, as the intervention is done at the level of the care providers.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Cluster-trial
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

June 9, 2022

First Posted

June 21, 2022

Study Start

October 1, 2022

Primary Completion

October 31, 2023

Study Completion

October 31, 2023

Last Updated

November 27, 2023

Record last verified: 2023-11

Locations